Vericel

VCEL63

$40.68arrow_drop_down1.46%-$0.60

VCEL63

$40.68

arrow_drop_down1.46%-$0.60

Performance History

Key Stats
Open	$41.26
Prev. Close	$41.27
EPS	0.01
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	39.78	41.31
52 Week Range	30.18	54.10

Ratios







EPS	0.01

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Vericel (VCEL)

Vericel Corp (VCEL) is a biopharmaceutical company specializing in the development and commercialization of cell therapies. The company's flagship product is MACI, an autologous cellularized scaffold used for the repair of symptomatic, full-thickness cartilage defects of the knee in adult patients. Vericel also offers Epicel, a permanent skin replacement for patients with deep dermal or full-thickness burns. Both products have been approved by the FDA and have shown significant clinical benefits.

VCEL stock has seen a steady increase in price over the years, reflecting the growing demand for regenerative medicine solutions. The company's market cap currently stands at $X billion, indicating strong investor confidence. The PEG ratio for Vericel Corp is X, suggesting a favorable valuation compared to its earnings growth rate. This indicates that the stock may be undervalued and could provide a potential investment opportunity.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Dominick C. Colangelo Esq.
Headquarters: Cambridge
Employees: 305
Exchange: NASDAQ

Keep an eye on Vericel

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Vericel's (VCEL) price per share?

The current price per share for Vericel (VCEL) is $40.68. The stock has seen a price change of -$0.61 recently, indicating a -1.47% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Vericel (VCEL)?

For Vericel (VCEL), the 52-week high is $54.1, which is 32.98% from the current price. The 52-week low is $30.18, the current price is 34.8% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Vericel (VCEL) a growth stock?

Vericel (VCEL) has shown an average price growth of -1.93% over the past three years. It has received a score of 52 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vericel as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Vericel (VCEL) stock price performance year to date (YTD)?

As of the latest data, Vericel (VCEL) has a year-to-date price change of 16.64%. Over the past month, the stock has experienced a price change of -9.03%. Over the last three months, the change has been -22.09%. Over the past six months, the figure is -14.39%. Looking at a longer horizon, the five-year price change stands at 168.01%.

help

Is Vericel (VCEL) a profitable company?

Vericel (VCEL) has a net income of -$3.18M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.64% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -11.45% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $197.52M, with a revenue growth rate of 20.17%, providing insight into the company's sales performance and growth. The gross profit is $135.58M. Operating income is noted at -$6.46M. Furthermore, the EBITDA is $2.86M.

help

What is the market capitalization of Vericel (VCEL)?

Vericel (VCEL) has a market capitalization of $2.06B. The average daily trading volume is 40.51, indicating the stock's liquidity and investor engagement.